Trial Profile
A retrospective study investigating effect of obesity in patients with metastatic colorectal cancer patients treated with bevacizumab-based chemotherapy combinations
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Dec 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 07 Dec 2016 New trial record
- 11 Oct 2016 Results presented at the 41st European Society for Medical Oncology Congress